Angioplasty News and Research

RSS

In angioplasty procedures, a balloon is fed through a catheter and used to prop open an artery that has become narrowed or blocked. In cases where stenting is appropriate, a stent mounted on a balloon is inserted and inflation of the balloon expands the stent against the blocked artery wall to hold the vessel open. The balloon is then deflated and the catheter is withdrawn. Stent treatment of arteries holds them open and improves blood flow to the heart. In cases where post-dilatation is needed, a high-pressure balloon is inflated inside a stent to help better place the stent against the vessel wall.

Spectranetics initiates enrollment in EXCITE clinical trial against femoropopliteal IRS

Spectranetics Corporation today announces the first patient enrollment in the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial.

27 Jun 2011

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

23 Jun 2011

High dose statins raise risk of diabetes: Study

According to the latest research taking a high-dose statin to lower cholesterol may increase risk of developing diabetes by as much as 12 percent, but the heart benefits of statins still outweigh the risks.

23 Jun 2011

UCLA study reports favorable outcomes for angioplasty with stents for low-risk heart patients

Heart bypass surgery is considered the gold standard for most patients with left main coronary artery disease, one of the most serious types of heart disease and one that affects thousands.

23 Jun 2011

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).

22 Jun 2011

Angioplasty may be an option for liver transplant candidates with heart disease

A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD). Details of the study are available in the July issue of Liver Transplantation, published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

22 Jun 2011

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

22 Jun 2011

Study finds PCI safe and feasible option for End-Stage Liver Disease patients with significant heart disease

22 Jun 2011

Only 10% of patients with heart attack transferred to another hospital for PCI in recommended time

Only about 10 percent of patients with a certain type of heart attack who need to be transferred to another hospital for a PCI are transferred within the recommended time of 30 minutes, according to a study in the June 22/29 issue of JAMA.

22 Jun 2011

Black patients with heart attack wait longer at hospitals to get life-saving procedures

Black patients having a heart attack wait longer at hospitals than white patients to get advanced procedures that will restore blood flow to their hearts, according to a University of Michigan Health System study.

21 Jun 2011

Genetic biomarker may help identify patients at increased risk of bypass surgery

Outcomes of bypass surgery to repair blocked arteries in the legs tend to be better in the roughly one-in-five people who have inherited a specific genetic variation from both parents, according to a study presented at the late-breaking clinical trials session of the Vascular Annual Meeting in Chicago on June 18, 2011.

20 Jun 2011

Boston Scientific to launch Mustang PTA Balloon Catheter worldwide

Boston Scientific Corporation today announced the global launch of its Mustang™ PTA Balloon Catheter, a highly deliverable 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures. The Company plans to launch the product immediately in the U.S., Europe and other international markets.

20 Jun 2011

Zilver PTX stent more effective than PTA for treatment of femoral artery lesions

Results of a prospective, randomized trial indicate that when treating femoral artery (SFA) lesions, the Zilver PTX Paclitaxel-Eluting Stent shows sustained effectiveness compared to percutaneous transluminal angioplasty, even in diabetic patients.

20 Jun 2011

Surgeons demonstrate potential genetic basis for varying outcomes of leg vein bypass surgery

Vascular Cures, a leading non-profit investing in research to develop breakthrough treatments for vascular disease, announced results that indicate there may be a genetic basis for the varying outcomes of bypass surgery in the legs.

20 Jun 2011

Patients still being enrolled in clinical trial for new peripheral vascular disease treatment

The first three patients to undergo an investigational surgical procedure for peripheral vascular disease that involves the patient's own stem cells continue to do well, reports the University of Louisville surgeon who is the principal investigator.

18 Jun 2011

Positive data from Ischemix CMX-2043 Phase 2a trial for peri-operative cardiac ischemia-reperfusion injury

Ischemix today announced positive top line data from a Phase 2a clinical trial of CMX-2043 for the prevention of peri-operative cardiac ischemia-reperfusion injury.

17 Jun 2011

Careful, well-designed studies needed for evaluating patients with MS: SIRF panel

Evaluating patients with multiple sclerosis who have narrowed jugular and azygos veins-and the value of widening those veins with angioplasty-warrants careful, well-designed research, noted members of a Society of Interventional Radiology Foundation's Research Consensus Panel.

17 Jun 2011

The Lancet publishes final 3-year data from landmark HORIZONS-AMI clinical trial

Data from the landmark HORIZONS-AMI clinical trial demonstrated that the administration of the anticoagulant medication bivalirudin enhanced survival compared to the use of heparin plus a glycoprotein (GP) IIb/IIIa inhibitor in heart attack patients undergoing angioplasty after 3 years. Use of a drug-eluting stent was also shown to be more effective than a bare-metal stent, with equivalent safety.

14 Jun 2011

New drug more effective than standard treatment to prevent heart-attack deaths

Robert Storey, Professor of Cardiology at the University of Sheffield's Department of Cardiovascular Science, presented findings today that confirm one in five deaths in the year following a heart attack could be prevented if a new drug, ticagrelor, was used instead of the standard treatment, clopidogrel.

13 Jun 2011

Ambulance diversion linked to high risk of mortality in patients with acute myocardial infarction

Among Medicare patients with heart attack in 4 California counties, diversion of ambulance traffic by the nearest emergency department for 12 hours or more was associated with an increased risk of death for up to one year, according to a study in the June 15 issue of JAMA.

13 Jun 2011

Angioplasty News and Research

Spectranetics initiates enrollment in EXCITE clinical trial against femoropopliteal IRS

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

High dose statins raise risk of diabetes: Study

UCLA study reports favorable outcomes for angioplasty with stents for low-risk heart patients

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Angioplasty may be an option for liver transplant candidates with heart disease

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Study finds PCI safe and feasible option for End-Stage Liver Disease patients with significant heart disease

Only 10% of patients with heart attack transferred to another hospital for PCI in recommended time

Black patients with heart attack wait longer at hospitals to get life-saving procedures

Genetic biomarker may help identify patients at increased risk of bypass surgery

Boston Scientific to launch Mustang PTA Balloon Catheter worldwide

Zilver PTX stent more effective than PTA for treatment of femoral artery lesions

Surgeons demonstrate potential genetic basis for varying outcomes of leg vein bypass surgery

Patients still being enrolled in clinical trial for new peripheral vascular disease treatment

Positive data from Ischemix CMX-2043 Phase 2a trial for peri-operative cardiac ischemia-reperfusion injury

Careful, well-designed studies needed for evaluating patients with MS: SIRF panel

The Lancet publishes final 3-year data from landmark HORIZONS-AMI clinical trial

New drug more effective than standard treatment to prevent heart-attack deaths

Ambulance diversion linked to high risk of mortality in patients with acute myocardial infarction

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News